Medically Integrated Pharmacy
Enhancing Patient-Centered Oncology Care
Through an integrated oncology care model, patients are provided a more comprehensive approach that brings together all aspects of a patient’s cancer treatment—including pharmacy services—within a single, coordinated site of care.
By embedding the pharmacy directly into the oncology practice, patients receive more streamlined, supportive, and effective treatment.
A Medically Integrated Dispensing Pharmacy (MIP) as defined by NCODA is a dispensing pharmacy within an oncology center of excellence that promotes a patient-centered, multidisciplinary team approach.
This innovative approach improves outcomes by providing seamless coordination, personalized support, and comprehensive services—all within the same site of care.
Traditional pharmacy dispensing is defined as the process of medication dispensing activities that occurs separately by a pharmacist from a prescription written by a physician. This dispensing model creates a fragmented approach to cancer care, limiting access to crucial clinical information beyond the prescription and medication list.
As a result, important treatment decisions may be made without a full picture of the patient’s needs, potentially impacting care and outcomes.
Integrated Pharmacy
Compared to Traditional Pharmacy in Oncology
The MIP model addresses these challenges by providing a more integrated and comprehensive approach, ensuring that oncology patients receive the most informed and effective treatment possible.
NCODA, in collaboration with an expert panel of leading oncology healthcare providers, led the development of patient-centered MIP standards to ensure the quality and safety for every patient that is prescribed oral anticancer medications.
These standards were adopted by ASCO and NCODA (Patient-Centered Medically Integrated Dispensing: ASCO/NCODA Standards) and published as the leading guidance for all members of the integrated oncology care team.
Patient-Centered Medically Integrated Dispensing: ASCO/NCODA Standards
READ STANDARDS
Why Medically Integrated Pharmacies Matter
In oncology, access to timely and effective treatment is critical. MIPs are designed to streamline the delivery of oral cancer therapies while enhancing communication between pharmacists, physicians, APPs, nurses, pharmacy technicians, and patients.
RESOURCES
Patient-Centered Care
Improved Medication Adherence
Enhanced Safety and Monitoring
Faster Access and Affordability
Cost Avoidance and Waste Reduction
Improved Patient Education
MIPs address key challenges in cancer treatment by reducing medication abandonment, improving access and affordability, and enhancing adherence. This patient-focused approach ensures timely access to oral anti-cancer medications (OAMs) while providing personalized care and ongoing support.
NCODA’s Pillars of MIP highlight the critical areas that drive better outcomes: abandonment, adherence, access & affordability, time to fill, education, satisfaction, and cost avoidance. By streamlining processes and offering proactive intervention, MIPs help patients stay on track with treatment, minimize financial burdens, and achieve improved overall care.
NCODA Pillars of Medically Integrated Dispensing
View Core Claims
OAM Patient Care
Abandonment
Adherence
Access and Affordability
Time to Fill
Education
Patient Satisfaction
Cost Avoidance
Stories of Impact from Integrated Oncology Practices
Hover to experience
Our Mission
NCODA’s Mission is to support medically integrated pharmacy practices and empower healthcare providers with the tools, resources, and best practices needed to deliver high-quality oncology care. We are dedicated to improving patient outcomes, enhancing medication access, and fostering collaboration across the oncology community.
LEARN MORE
Advancing Quality Cancer Care
Assets & Link
HOME
MEMBER LOGIN
BECOME A MEMBER